1. Product
Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2. Research
Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive
Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market Drivers,
Challenges, Trends
4. Voice
of Customer
5.
Global Cloning & Mutagenesis
Market Outlook
5.1. Market
Size & Forecast
5.1.1. By
Value
5.2. Market
Share & Forecast
5.2.1.
By
Gene Type (Standard v/s Complex)
5.2.2.
By
Product Type (Cloning Kits v/s Mutagenesis Kits)
5.2.3.
By
Technique (Topo PCR Cloning, Blunt End Cloning, Seamless Cloning, Site-Directed
Mutagenesis, Others)
5.2.4.
By
Application (Gene Synthesis, Gene Expression, Gene Therapy, Vaccine Research,
Others)
5.2.5.
By End
User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions,
Others)
5.2.6.
By
Region
5.2.7. By
Company (2022)
5.3. Market
Map
5.3.1. By
Gene Type
5.3.2. By
Product Type
5.3.3. By
Technique
5.3.4. By
Application
5.3.5. By End
User
5.3.6. By
Region
6.
North America Cloning & Mutagenesis
Market Outlook
6.1. Market
Size & Forecast
6.1.1. By
Value
6.2. Market
Share & Forecast
6.2.1.
By Gene
Type
6.2.2.
By
Product Type
6.2.3.
By
Technique
6.2.4.
By
Application
6.2.5.
By End
User
6.2.6. By
Country
6.3. North
America: Country Analysis
6.3.1. United
States Cloning & Mutagenesis Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Gene Type
6.3.1.2.2.
By Product Type
6.3.1.2.3.
By Technique
6.3.1.2.4.
By Application
6.3.1.2.5.
By End User
6.3.2. Canada
Cloning & Mutagenesis Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Gene Type
6.3.2.2.2.
By Product Type
6.3.2.2.3.
By Technique
6.3.2.2.4.
By Application
6.3.2.2.5.
By End User
6.3.3. Mexico
Cloning & Mutagenesis Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Gene Type
6.3.3.2.2.
By Product Type
6.3.3.2.3.
By Technique
6.3.3.2.4.
By Application
6.3.3.2.5.
By End User
7.
Europe Cloning & Mutagenesis
Market Outlook
7.1. Market
Size & Forecast
7.1.1. By
Value
7.2. Market
Share & Forecast
7.2.1.
By
Gene Type
7.2.2.
By
Product Type
7.2.3.
By
Technique
7.2.4.
By
Application
7.2.5.
By End
User
7.2.6.
By
Country
7.3. Europe:
Country Analysis
7.3.1. France
Cloning & Mutagenesis Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Gene Type
7.3.1.2.2.
By Product Type
7.3.1.2.3.
By Technique
7.3.1.2.4.
By Application
7.3.1.2.5.
By End User
7.3.2. Germany
Cloning & Mutagenesis Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Gene Type
7.3.2.2.2.
By Product Type
7.3.2.2.3.
By Technique
7.3.2.2.4.
By Application
7.3.2.2.5.
By End User
7.3.3. United
Kingdom Cloning & Mutagenesis Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Gene Type
7.3.3.2.2.
By Product Type
7.3.3.2.3.
By Technique
7.3.3.2.4.
By Application
7.3.3.2.5.
By End User
7.3.4. Italy
Cloning & Mutagenesis Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Gene Type
7.3.4.2.2.
By Product Type
7.3.4.2.3.
By Technique
7.3.4.2.4.
By Application
7.3.4.2.5.
By End User
7.3.5. Spain
Cloning & Mutagenesis Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Gene Type
7.3.5.2.2.
By Product Type
7.3.5.2.3.
By Technique
7.3.5.2.4.
By Application
7.3.5.2.5.
By End User
8.
Asia-Pacific Cloning & Mutagenesis Market Outlook
8.1. Market
Size & Forecast
8.1.1. By
Value
8.2. Market
Share & Forecast
8.2.1.
By
Gene Type
8.2.2.
By
Product Type
8.2.3.
By
Technique
8.2.4.
By
Application
8.2.5.
By End
User
8.2.6. By
Country
8.3. Asia-Pacific:
Country Analysis
8.3.1. China
Cloning & Mutagenesis Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Gene Type
8.3.1.2.2.
By Product Type
8.3.1.2.3.
By Technique
8.3.1.2.4.
By Application
8.3.1.2.5.
By End User
8.3.2. India
Cloning & Mutagenesis Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Gene Type
8.3.2.2.2.
By Product Type
8.3.2.2.3.
By Technique
8.3.2.2.4.
By Application
8.3.2.2.5.
By End User
8.3.3. Japan
Cloning & Mutagenesis Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Gene Type
8.3.3.2.2.
By Product Type
8.3.3.2.3.
By Technique
8.3.3.2.4.
By Application
8.3.3.2.5.
By End User
8.3.4. South
Korea Cloning & Mutagenesis Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Gene Type
8.3.4.2.2.
By Product Type
8.3.4.2.3.
By Technique
8.3.4.2.4.
By Application
8.3.4.2.5.
By End User
8.3.5. Australia
Cloning & Mutagenesis Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Gene Type
8.3.5.2.2.
By Product Type
8.3.5.2.3.
By Technique
8.3.5.2.4.
By Application
8.3.5.2.5.
By End User
9.
South America Cloning & Mutagenesis
Market Outlook
9.1. Market
Size & Forecast
9.1.1. By
Value
9.2. Market
Share & Forecast
9.2.1.
By
Gene Type
9.2.2.
By
Product Type
9.2.3.
By
Technique
9.2.4.
By
Application
9.2.5.
By End
User
9.2.6. By
Country
9.3. South America:
Country Analysis
9.3.1. Brazil
Cloning & Mutagenesis Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Gene Type
9.3.1.2.2.
By Product Type
9.3.1.2.3.
By Technique
9.3.1.2.4.
By Application
9.3.1.2.5.
By End User
9.3.2. Argentina
Cloning & Mutagenesis Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Gene Type
9.3.2.2.2.
By Product Type
9.3.2.2.3.
By Technique
9.3.2.2.4.
By Application
9.3.2.2.5.
By End User
9.3.3. Colombia
Cloning & Mutagenesis Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Gene Type
9.3.3.2.2.
By Product Type
9.3.3.2.3.
By Technique
9.3.3.2.4.
By Application
9.3.3.2.5.
By End User
10. Middle
East and Africa Cloning & Mutagenesis Market Outlook
10.1.
Market Size & Forecast
10.1.1. By
Value
10.2.
Market Share & Forecast
10.2.1.
By
Gene Type
10.2.2.
By
Product Type
10.2.3.
By
Technique
10.2.4.
By
Application
10.2.5.
By End
User
10.2.6. By
Country
10.3.
MEA: Country Analysis
10.3.1. South
Africa Cloning & Mutagenesis Market Outlook
10.3.1.1. Market
Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market
Share & Forecast
10.3.1.2.1.
By Gene Type
10.3.1.2.2.
By Product Type
10.3.1.2.3.
By Technique
10.3.1.2.4.
By Application
10.3.1.2.5.
By End User
10.3.2. Saudi
Arabia Cloning & Mutagenesis Market Outlook
10.3.2.1. Market
Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market
Share & Forecast
10.3.2.2.1.
By Gene Type
10.3.2.2.2.
By Product Type
10.3.2.2.3.
By Technique
10.3.2.2.4.
By Application
10.3.2.2.5.
By End User
10.3.3. UAE
Cloning & Mutagenesis Market Outlook
10.3.3.1. Market
Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market
Share & Forecast
10.3.3.2.1.
By Gene Type
10.3.3.2.2.
By Product Type
10.3.3.2.3.
By Technique
10.3.3.2.4.
By Application
10.3.3.2.5.
By End User
11. Market
Dynamics
11.1.
Drivers
11.2.
Challenges
12. Market
Trends & Developments
12.1.
Recent Developments
12.2.
Mergers & Acquisitions
12.3.
Product Launches
13. Competitive
Landscape
13.1.
Business Overview
13.2.
Product Offerings
13.3.
Recent Developments
13.4.
Financials (As Reported)
13.5.
Key Personnel
13.6.
SWOT Analysis
13.6.1. Agilent
Technologies, Inc.
13.6.2. Eurofins
Scientific SE
13.6.3. Sartorius
AG
13.6.4. Collecta,
Inc.
13.6.5. Codex
DNA Inc.
13.6.6. Lonza
Group AG
13.6.7. Charles
River Laboratories International, Inc.
13.6.8. TransGene
Biotech Co. Ltd.
13.6.9. Takara
Bio, Inc.
13.6.10.
Thermo Fisher Scientific Inc.
Strategic
Recommendations